Attention Deficit Hyperactivity Disorder and Comorbid Conditions in Adults: Case Studies in Diagnosis and Treatment CME

Thomas J. Spencer, MD Author Information and Disclosures

Release Date: March 24, 2008; Valid for credit through March 24, 2009

Credits Available
Physicians - maximum of 1.5 AMA PRA Category 1 Credit(s)™ for physicians

This CME activity was developed to be distributed on Medscape.

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the educational content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Copyright © 2008 Physicians Academy
McNeil Pediatrics, Ortho-McNeil
Learning Objectives
Upon completion of this activity, participants should be able to:
  1. Conduct a comprehensive diagnostic evaluation for ADHD in adults.
  2. Assess the presence of comorbid psychiatric conditions in adults with ADHD.
  3. Implement and monitor a treatment plan for the adult with ADHD.
  4. Identify those patients who might benefit from combination therapy to manage their ADHD and comorbid psychiatric conditions.
Author Disclosures
Thomas J. Spencer, MD
Disclosure: Grant/Research Support: Cephalon, Eli Lilly & Company, GlaxoSmithKline, McNeil Pharmaceutical, NIMH, Novartis Pharmaceuticals, Pfizer Inc, Shire Laboratories Inc; Speakers' Bureau: Eli Lilly & Company, GlaxoSmithKline, McNeil Pharmaceutical, Novartis Pharmaceuticals, Shire Laboratories Inc; Advisory Board: Cephalon, Eli Lilly & Company, GlaxoSmithKline, McNeil Pharmaceutical, Novartis Pharmaceuticals, Pfizer Inc, Shire Laboratories Inc.
 
Physicians Academy for Clinical and Management Excellence
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of The Physicians Academy for Clinical and Management Excellence. Physicians Academy is accredited by the ACCME to provide continuing medical education for physicians.

The Physicians Academy for Clinical and Management Excellence designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.